Viewing Study NCT06418594


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-04-13 @ 1:08 AM
Study NCT ID: NCT06418594
Status: RECRUITING
Last Update Posted: 2024-12-10
First Post: 2024-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
Sponsor: Beijing 302 Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module